Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychopharmacology | 10 | 2022 | 148 | 4.100 |
Why?
|
| Antipsychotic Agents | 19 | 2022 | 3061 | 2.150 |
Why?
|
| Algorithms | 19 | 2020 | 13982 | 1.180 |
Why?
|
| Bipolar Disorder | 9 | 2020 | 5078 | 0.710 |
Why?
|
| Antidepressive Agents | 7 | 2020 | 2890 | 0.670 |
Why?
|
| Prazosin | 3 | 2022 | 95 | 0.640 |
Why?
|
| Stress Disorders, Post-Traumatic | 5 | 2022 | 4555 | 0.610 |
Why?
|
| Anti-Anxiety Agents | 3 | 2016 | 397 | 0.580 |
Why?
|
| Electroconvulsive Therapy | 5 | 2020 | 502 | 0.530 |
Why?
|
| Psychotic Disorders | 6 | 2022 | 3193 | 0.530 |
Why?
|
| Drug Synergism | 2 | 2019 | 1752 | 0.520 |
Why?
|
| Obsessive-Compulsive Disorder | 3 | 2019 | 1489 | 0.490 |
Why?
|
| Antidepressive Agents, Second-Generation | 3 | 2013 | 489 | 0.480 |
Why?
|
| Haloperidol | 5 | 2022 | 389 | 0.480 |
Why?
|
| Clinical Protocols | 3 | 2014 | 1440 | 0.440 |
Why?
|
| Risperidone | 4 | 2020 | 379 | 0.430 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1079 | 0.420 |
Why?
|
| REM Sleep Behavior Disorder | 1 | 2013 | 108 | 0.410 |
Why?
|
| Neurotransmitter Agents | 1 | 2016 | 663 | 0.410 |
Why?
|
| Benzodiazepines | 5 | 2022 | 1131 | 0.400 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2754 | 0.350 |
Why?
|
| Depressive Disorder | 4 | 2019 | 3726 | 0.350 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 174 | 0.320 |
Why?
|
| Drug Therapy, Combination | 6 | 2022 | 6498 | 0.310 |
Why?
|
| Schizophrenia | 7 | 2013 | 6915 | 0.300 |
Why?
|
| Dementia | 2 | 2020 | 2650 | 0.290 |
Why?
|
| Anxiety Disorders | 2 | 2016 | 2714 | 0.280 |
Why?
|
| Practice Guidelines as Topic | 3 | 2016 | 7475 | 0.260 |
Why?
|
| Psychomotor Agitation | 2 | 2022 | 305 | 0.230 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2017 | 919 | 0.220 |
Why?
|
| Adrenergic Antagonists | 1 | 2022 | 26 | 0.210 |
Why?
|
| Promethazine | 1 | 2022 | 29 | 0.200 |
Why?
|
| Chest Pain | 1 | 2009 | 1106 | 0.200 |
Why?
|
| Dreams | 1 | 2022 | 146 | 0.190 |
Why?
|
| Lorazepam | 1 | 2022 | 154 | 0.190 |
Why?
|
| Fluvoxamine | 1 | 2020 | 78 | 0.170 |
Why?
|
| Clomipramine | 1 | 2019 | 54 | 0.170 |
Why?
|
| Pirenzepine | 1 | 1999 | 116 | 0.170 |
Why?
|
| Antimanic Agents | 2 | 2015 | 520 | 0.160 |
Why?
|
| Irritable Mood | 1 | 2020 | 194 | 0.160 |
Why?
|
| Citalopram | 1 | 2020 | 402 | 0.150 |
Why?
|
| Psychotropic Drugs | 2 | 2020 | 883 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2008 | 2001 | 0.150 |
Why?
|
| Social Isolation | 1 | 2020 | 362 | 0.140 |
Why?
|
| Telecommunications | 1 | 2017 | 80 | 0.140 |
Why?
|
| Telemedicine | 3 | 2020 | 3018 | 0.130 |
Why?
|
| Naltrexone | 1 | 1998 | 317 | 0.130 |
Why?
|
| Depressive Disorder, Major | 2 | 2018 | 4744 | 0.130 |
Why?
|
| Humans | 41 | 2022 | 760613 | 0.130 |
Why?
|
| Affective Symptoms | 1 | 2018 | 416 | 0.130 |
Why?
|
| Comorbidity | 3 | 2020 | 10553 | 0.130 |
Why?
|
| Patient Care Team | 2 | 2017 | 2511 | 0.120 |
Why?
|
| Evidence-Based Medicine | 3 | 2012 | 3696 | 0.120 |
Why?
|
| Narcotic Antagonists | 1 | 1998 | 583 | 0.110 |
Why?
|
| Videoconferencing | 1 | 2016 | 203 | 0.110 |
Why?
|
| Sulpiride | 1 | 2013 | 15 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 894 | 0.110 |
Why?
|
| Mesoridazine | 1 | 1991 | 2 | 0.100 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2018 | 1988 | 0.100 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2011 | 24 | 0.100 |
Why?
|
| Mianserin | 1 | 2011 | 50 | 0.100 |
Why?
|
| Triglycerides | 1 | 1999 | 2476 | 0.100 |
Why?
|
| Trazodone | 1 | 2011 | 68 | 0.100 |
Why?
|
| Curriculum | 1 | 2005 | 3718 | 0.100 |
Why?
|
| Piperazines | 2 | 2013 | 2525 | 0.100 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 8552 | 0.090 |
Why?
|
| Dibenzazepines | 1 | 1990 | 26 | 0.090 |
Why?
|
| Dibenzothiazepines | 1 | 2010 | 102 | 0.080 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2011 | 432 | 0.080 |
Why?
|
| Quinolones | 1 | 2013 | 377 | 0.080 |
Why?
|
| Weight Gain | 1 | 1999 | 2347 | 0.080 |
Why?
|
| Lithium Carbonate | 1 | 2010 | 179 | 0.080 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 1988 | 74 | 0.080 |
Why?
|
| Phobic Disorders | 1 | 2010 | 437 | 0.080 |
Why?
|
| Alcoholism | 1 | 1998 | 1961 | 0.070 |
Why?
|
| Triazines | 1 | 2010 | 310 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 2496 | 0.070 |
Why?
|
| Adult | 9 | 2020 | 220007 | 0.070 |
Why?
|
| Clozapine | 1 | 1990 | 506 | 0.070 |
Why?
|
| Triazoles | 1 | 2011 | 904 | 0.070 |
Why?
|
| Fluoxetine | 1 | 2010 | 733 | 0.070 |
Why?
|
| Internship and Residency | 2 | 2005 | 5870 | 0.060 |
Why?
|
| Thiazoles | 1 | 2013 | 1511 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2003 | 10826 | 0.060 |
Why?
|
| Community Mental Health Services | 1 | 2007 | 392 | 0.060 |
Why?
|
| Drug Administration Schedule | 2 | 2020 | 4899 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2010 | 2647 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 3701 | 0.050 |
Why?
|
| Cohort Effect | 1 | 2003 | 39 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5325 | 0.050 |
Why?
|
| International Cooperation | 2 | 2018 | 1433 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2011 | 1879 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8623 | 0.040 |
Why?
|
| Cooperative Behavior | 2 | 2017 | 1500 | 0.040 |
Why?
|
| Female | 10 | 2020 | 391246 | 0.040 |
Why?
|
| Decision Trees | 1 | 2020 | 506 | 0.040 |
Why?
|
| Program Evaluation | 2 | 2017 | 2493 | 0.040 |
Why?
|
| Male | 10 | 2020 | 359718 | 0.040 |
Why?
|
| Hospitals, Psychiatric | 1 | 2018 | 320 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 1993 | 6015 | 0.040 |
Why?
|
| Hypertriglyceridemia | 1 | 1999 | 316 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2002 | 1392 | 0.030 |
Why?
|
| Psychiatry | 2 | 2005 | 1689 | 0.030 |
Why?
|
| Aged | 5 | 2020 | 169143 | 0.030 |
Why?
|
| Organizational Innovation | 1 | 2017 | 536 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 844 | 0.030 |
Why?
|
| China | 1 | 2018 | 2339 | 0.030 |
Why?
|
| Research Design | 2 | 2003 | 6180 | 0.020 |
Why?
|
| United States | 5 | 2020 | 72448 | 0.020 |
Why?
|
| Age of Onset | 1 | 2018 | 3302 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 12968 | 0.020 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1989 | 165 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2003 | 9288 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2018 | 1425 | 0.020 |
Why?
|
| Personality Disorders | 1 | 1993 | 721 | 0.020 |
Why?
|
| Mental Disorders | 2 | 2005 | 6796 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2017 | 2963 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4279 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 1822 | 0.020 |
Why?
|
| Internet | 1 | 1998 | 3078 | 0.020 |
Why?
|
| Texas | 1 | 2006 | 401 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3448 | 0.010 |
Why?
|
| Middle Aged | 5 | 2018 | 220359 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2010 | 64981 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 2006 | 457 | 0.010 |
Why?
|
| Pregnancy | 2 | 2020 | 29746 | 0.010 |
Why?
|
| Quality of Health Care | 2 | 2017 | 4360 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1990 | 1535 | 0.010 |
Why?
|
| Schizophrenic Psychology | 1 | 1990 | 1646 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15686 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 167960 | 0.010 |
Why?
|
| Veterans | 1 | 2014 | 2642 | 0.010 |
Why?
|
| Electric Stimulation Therapy | 1 | 2006 | 613 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4775 | 0.010 |
Why?
|
| Hospitalization | 1 | 1999 | 10789 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 40139 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 58980 | 0.010 |
Why?
|
| Medication Adherence | 1 | 2008 | 2165 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15840 | 0.010 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2006 | 1469 | 0.010 |
Why?
|
| Disease Management | 1 | 2006 | 2514 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1990 | 8055 | 0.010 |
Why?
|
| Brain | 1 | 1990 | 26951 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1990 | 80345 | 0.000 |
Why?
|
| Social Values | 1 | 1981 | 225 | 0.000 |
Why?
|
| Physician-Patient Relations | 1 | 1981 | 3242 | 0.000 |
Why?
|
| Clinical Competence | 1 | 1981 | 4783 | 0.000 |
Why?
|
Concepts
(149)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_